HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Winston Evering Selected Research
Winston Evering Research Topics
Disease
4
Neoplasms (Cancer)
10/2019 - 10/2012
2
Melanoma (Melanoma, Malignant)
02/2015 - 10/2012
2
Inflammation (Inflammations)
06/2014 - 04/2008
1
Adenocarcinoma
10/2019
1
Glucose Intolerance
11/2017
1
Breast Neoplasms (Breast Cancer)
11/2017
1
Flushing
10/2012
1
Hyperplasia
10/2012
1
Autoimmune Diseases (Autoimmune Disease)
07/2011
1
Paralysis (Palsy)
07/2011
1
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
07/2011
1
Multiple Sclerosis
07/2011
1
Renal Cell Carcinoma (Grawitz Tumor)
12/2008
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2008
1
Vascular System Injuries
11/2008
1
Corneal Opacity
04/2008
1
Edema (Dropsy)
04/2008
1
Contact Dermatitis (Eczema, Contact)
07/2005
1
Common Cold
07/2005
Drug/Important Bio-Agent (IBA)
3
Proteins (Proteins, Gene)
FDA Link
10/2019 - 10/2012
1
Pharmaceutical Preparations
IBA
10/2019
1
palbociclib
IBA
11/2017
1
Cancer Vaccines
IBA
02/2015
1
Monoclonal Antibodies
IBA
06/2014
1
Mitogens
IBA
10/2012
1
Interleukin-8 (Interleukin 8)
IBA
10/2012
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
10/2012
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
10/2012
1
Cytokines
IBA
10/2012
1
mirdametinib
IBA
10/2012
1
PF-04880594
IBA
10/2012
1
Antibodies
IBA
07/2011
1
Interleukin-7 (Interleukin 7)
IBA
07/2011
1
Interferons
IBA
07/2011
1
Imatinib Mesylate (Gleevec)
FDA Link
12/2008
1
Sunitinib (Sutent)
FDA Link
12/2008
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
12/2008
1
N- ((5- (3- (4,6- difluoro- 1H- benzimidazol- 2- yl)- 1H- indazol- 5- yl)- 4- methylpyridin- 3- yl)methyl)ethanamine
IBA
11/2008
1
Poloxamer (Poloxamer 407)
IBA
04/2008
1
Excipients (Suspending Agents)
IBA
04/2008
1
rupintrivir
IBA
07/2005
1
Protease Inhibitors (Protease Inhibitor)
IBA
07/2005
Therapy/Procedure
1
Immunotherapy
02/2015
1
Therapeutics
02/2015